Cardiovascular Adverse Events Associated With New-Generation Androgen Receptor Pathway Inhibitors (ARPI) for Prostate Cancer: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS)
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer October 2023 21(5):594-601 - Subject
- Language
- ISSN
- 1558-7673